Search
for
Sort by
Research 331–360 of 343
- Oral Presentations
- Subject Index
- Secondary Syphilis in Cali, Colombia: New Concepts in Disease Pathogenesis
- Activation of TRPV3 Regulates Inflammatory Actions of Human Epidermal Keratinocytes
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- Pili Torti: A Feature of Numerous Congenital and Acquired Conditions
- Medical Dermatology
- An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- Modulating the Gut–Skin Axis in Dermatological Diseases: Mechanisms and Clinical Applications of Probiotics, Prebiotics, Synbiotics, and Postbiotics
- Hair restoration surgery: pre-surgical considerations and pitfalls
- Surgical Management of Scarring Alopecia
- Acne Vulgaris
- Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations
- PA11 A rare case of a severe papulopustular dermatosis secondary to a germline <i>EGFR</i> mutation
- PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors)
- A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex
- The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients
- Rosacea: I. Etiology, pathogenesis, and subtype classification
- Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice
- Isotretinoin treatment of acne and related disorders: An update
- Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara<sup>®</sup>) and EE/LNG (Microgynon<sup>®</sup>)
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Azelaic Acid: Mechanisms of Action and Clinical Applications
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs